Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

Simple item page
dc.contributor.authorThe ATAC (Arimidex, T.
dc.contributor.authorGill, P.
dc.date.issued2003
dc.descriptionCopyright © 2003 American Cancer Society
dc.identifier.citationCancer, 2003; 98(9):1802-1810
dc.identifier.issn0008-543X
dc.identifier.orcidGill, P. [0000-0001-7310-2970]
dc.identifier.urihttp://hdl.handle.net/2440/42067
dc.language.isoen
dc.publisherAmerican Cancer Society
dc.source.urihttp://www3.interscience.wiley.com/cgi-bin/fulltext/105560649/HTMLSTART
dc.subjectBreast Cancer
dc.titleAnastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Surgery publications